Adding bevacizumab to paclitaxel in the first-line treatment of metastatic breast cancer
- PMID: 19080734
Adding bevacizumab to paclitaxel in the first-line treatment of metastatic breast cancer
Comment on
-
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.N Engl J Med. 2007 Dec 27;357(26):2666-76. doi: 10.1056/NEJMoa072113. N Engl J Med. 2007. PMID: 18160686 Clinical Trial.